| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 13 Oct 2026 |
8-K: Shareholder Director Nominations; Other Events
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 15 Jun 2026 |
8-K: Regulation FD Disclosure
On June 12, 2026, Nephros, Inc. (the “Company”) posted an updated 2026 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1. |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition
Nephros Announces Financial Results for Quarter Ended March 31, 2026 |
| 27 Mar 2026 |
8-K: Regulation FD Disclosure
On March 27, 2026, Nephros, Inc. (the “Company”) posted an updated 2026 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1. |
| 26 Nov 2025 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
On November 21, 2025, Nephros, Inc. (the “Company”) entered into a license and supply agreement (the “License and Supply Agreement”) with Medica S.p.A. (“Medica”), an Italy-based medical product manufacturing company, for the marketing a... |
| 11 Aug 2025 |
8-K: Results of Operations and Financial Condition
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 16 Jun 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On June 16, 2025, Nephros, Inc. (the “Company”) held its 2025 Annual Meeting of the Stockholders (the “Annual Meeting”). At the Annual Meeting: |
| 08 May 2025 |
8-K: Results of Operations and Financial Condition
Nephros Announces Financial Results for Quarter Ended March 31, 2025 |
| 28 Apr 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 01 Apr 2025 |
8-K: Regulation FD Disclosure
On March 31, 2025, Nephros, Inc. (the “Company”) posted an updated 2024 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1. |
| 06 Mar 2025 |
8-K: Results of Operations and Financial Condition
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 04 Mar 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 13 Nov 2024 |
8-K: Results of Operations and Financial Condition
Nephros Announces Financial Results for Quarter Ended September 30, 2024 |
| 26 Aug 2024 |
8-K: Regulation FD Disclosure
On August 26, 2024, Nephros, Inc. (the “Company”) posted an updated 2024 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1. |
| 24 May 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
(a) Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; (ii) the Prior Plan’s Available Res... |
| 09 May 2024 |
8-K: Results of Operations and Financial Condition
Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 |
| 01 May 2024 |
8-K: Regulation FD Disclosure
On May 1, 2024, Nephros, Inc. (the “Company”) will present a 2024 Corporate Presentation at the Planet MicroCap Showcase: VEGAS 2024. A copy of this presentation is furnished herewith as Exhibit 99.1. |
| 07 Mar 2024 |
8-K: Results of Operations and Financial Condition
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results |
Loading...